Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OZODROP for Ocular Microbial Flora Reduction
NCT04087733Phase 4Completed
- Sponsor
- University of Molise
- Start
- Oct 2019
- Primary completion
- Jun 2020
- Modality
- Device-based Delivery, Targeted Liposomes, Stealth (PEGylated) Liposomes
- Countries
- 1
01
Overview
A Phase 4 trial of OZODROP in ocular infection, sponsored by University of Molise. Started Oct 2019; status: completed.
02
Drugs
OZODROP
03
Conditions
ocular infection
Beyond the preview
Go deeper on NCT04087733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04087733.